Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Martinez

Showing results (401-410 of 463) with videos related to

Pageof 47
Sort By:
Human Molecular Genetics|August 16, 2012
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's diseaseMargaux F Keller, Mohamad Saad, Jose Bras, et al.
Human Molecular Genetics|December 11, 2012
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's diseasePeter Holmans, Valentina Moskvina, Lesley Jones, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockadeCarlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from ImmunotherapyCristina Carrato, Francesc Alameda, Anna Esteve-Codina, et al.
International Journal of Molecular Sciences|April 23, 2022
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid CarcinomaJulia C Thierauf, Alex A Farahani, B Iciar Indave, et al.
Neuro-Oncology|April 25, 2020
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)Carmen Balana, Maria Angeles Vaz, Juan Manuel Sepúlveda, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 25, 2021
How to Predict Postoperative Complications After Early Laparoscopic Cholecystectomy for Acute Cholecystitis: the Chole-Risk ScoreMarcello Di Martino, Ismael Mora-Guzmán, Víctor Vaello Jodra, et al.
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2013
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphismStephan Klebe, Jean-Louis Golmard, Michael A Nalls, et al.
JAMA Neurology|August 8, 2013
Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic riskValentina Moskvina, Denise Harold, GianCarlo Russo, et al.
Pageof 47

Showing results (401-410 of 463) with videos related to

Sort By:
Pageof 47
Human Molecular Genetics|August 16, 2012
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's diseaseMargaux F Keller, Mohamad Saad, Jose Bras, et al.
Human Molecular Genetics|December 11, 2012
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's diseasePeter Holmans, Valentina Moskvina, Lesley Jones, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockadeCarlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from ImmunotherapyCristina Carrato, Francesc Alameda, Anna Esteve-Codina, et al.
International Journal of Molecular Sciences|April 23, 2022
Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid CarcinomaJulia C Thierauf, Alex A Farahani, B Iciar Indave, et al.
Neuro-Oncology|April 25, 2020
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)Carmen Balana, Maria Angeles Vaz, Juan Manuel Sepúlveda, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 25, 2021
How to Predict Postoperative Complications After Early Laparoscopic Cholecystectomy for Acute Cholecystitis: the Chole-Risk ScoreMarcello Di Martino, Ismael Mora-Guzmán, Víctor Vaello Jodra, et al.
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2013
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphismStephan Klebe, Jean-Louis Golmard, Michael A Nalls, et al.
JAMA Neurology|August 8, 2013
Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic riskValentina Moskvina, Denise Harold, GianCarlo Russo, et al.
Pageof 47